1
00:00:00,330 --> 00:00:07,260
So can you say your name and your title? On Sunday, Douglas on a research group leader in the Jenner Institute.

2
00:00:08,190 --> 00:00:12,989
Okay, thanks very much. So starting from your earliest interest in your subject,

3
00:00:12,990 --> 00:00:17,640
can you just give me a kind of three or four sentence account of how you got to where you are now?

4
00:00:19,440 --> 00:00:20,970
I'm looking in three or four senses.

5
00:00:21,600 --> 00:00:30,520
So I first did a short project with the Gender Institute when I was a medical student, which would have been 2006 or 2007.

6
00:00:30,590 --> 00:00:35,100
Yeah. So it just gave the thought that, you see, we were done and you were going to be a doctor.

7
00:00:35,100 --> 00:00:40,470
Is that when you applied for medicine? Yeah, that's right. Yeah. So I was a clinical medical student in Oxford.

8
00:00:40,710 --> 00:00:55,650
I graduated in 2007. I then did a short project alongside my clinical foundation training four month projects in the journal,

9
00:00:55,740 --> 00:01:05,670
which turned into a three year Ph.D. on the development of vaccines against the blood stage of malaria.

10
00:01:07,320 --> 00:01:12,360
That was 2009 to 2012. Subsequently, I.

11
00:01:15,130 --> 00:01:22,750
Did some further clinical training in the NHS. I was a NHS trainee, an infectious disease in general medicine.

12
00:01:24,190 --> 00:01:31,569
I did some postdoctoral research and then in 2016 I got a Wellcome Trust Fellowship and came

13
00:01:31,570 --> 00:01:38,710
out to full time research and I've been leading my group in that in the journal since then,

14
00:01:38,740 --> 00:01:41,500
working full time in research.

15
00:01:42,100 --> 00:01:49,120
So as I understand this, two aspects to you is that you are actually interested in the the immune system and allergenicity and how vaccines work.

16
00:01:49,810 --> 00:01:57,610
But you also have this interest in how you actually manufacture them to a point where you've got a product that can be delivered to the world.

17
00:01:57,880 --> 00:02:06,340
Yeah. So that my original primary interest is also translational and clinical research.

18
00:02:06,610 --> 00:02:14,560
So developing new malaria vaccines and then subsequently I've moved towards developing a new candidate rabies vaccine as well.

19
00:02:16,750 --> 00:02:26,680
And the interest in money, my interest in manufacturing, I guess, has come from from two things.

20
00:02:27,610 --> 00:02:31,599
The primary one was really an accident of fate.

21
00:02:31,600 --> 00:02:36,110
And it was it was the need to solve a problem in my rabies vaccine programme.

22
00:02:37,090 --> 00:02:46,090
So my rabies vaccine candidate is, is based upon an adenoviral vector very similar to Chadox1 COVID vaccine.

23
00:02:47,830 --> 00:02:57,940
And I had said in a grant application that I would take a technology that had been developed by someone else in the DNA previously,

24
00:02:57,940 --> 00:03:06,310
which could make bats make these up in the virus vaccine stable at room temperature for, you know, storage and distribution outside fridges.

25
00:03:08,020 --> 00:03:13,959
And I'd said I'd do this with this rabies vaccine and I would do it to clinical grade,

26
00:03:13,960 --> 00:03:23,170
such as good manufacturing practice with GMP compliant, easy, because really rabies vaccine is mainly needed in hot places, basically.

27
00:03:23,290 --> 00:03:29,290
Exactly. Yeah. And I was quite naive about what it would take to do that.

28
00:03:29,290 --> 00:03:39,909
But it turned out that to do that, we needed more vaccine and higher concentration and in a different mixture of salts and

29
00:03:39,910 --> 00:03:46,540
sugars from what's our clinical biomanufacturing facility or a small in-house pilot,

30
00:03:46,660 --> 00:03:50,590
clinical grade manufacturing vaccine manufacturing facility led by Cath Green.

31
00:03:51,010 --> 00:03:55,540
We needed we needed more vaccine, a different vaccine from from the way they had made it before.

32
00:03:55,720 --> 00:04:02,770
And so to try and do this project, to make this temperature stable, rabies vaccine,

33
00:04:04,120 --> 00:04:10,540
which ultimately didn't work, or at least the temperature stable bits of it, I had to redevelop.

34
00:04:11,030 --> 00:04:14,650
I had to develop a new way of making out in the virus for the placebo.

35
00:04:17,020 --> 00:04:24,810
Can I just pause it? So through 2017, 2018, 2019.

36
00:04:26,490 --> 00:04:35,100
I developed a new wave of for our CBF to make clinical grade adenovirus vaccines and previously the way the way

37
00:04:35,100 --> 00:04:41,639
they had done it was really only suitable to make a few hundred or a couple of thousand doses of a vaccine.

38
00:04:41,640 --> 00:04:51,480
It wasn't scalable, it was very manual and the way we developed was suitable to be scalable.

39
00:04:51,600 --> 00:04:57,090
We were only planning to do it at small scale and for the rabies project we only did do it on a small scale,

40
00:04:58,230 --> 00:05:02,580
but we did it in a way that could go to larger scale.

41
00:05:02,790 --> 00:05:03,780
They have a big need it.

42
00:05:05,220 --> 00:05:20,040
And we also did it using materials and equipment that was very standard, you know, off the shelf, single use disposable things,

43
00:05:20,040 --> 00:05:26,530
which makes it much easier to set up in a new facility because you're not you're not trying to fit the manufacturing to a,

44
00:05:27,090 --> 00:05:32,129
you know, whatever stainless steel, you know, equipment they already have installed.

45
00:05:32,130 --> 00:05:44,910
You can just buy the off the shelf disposable things. So we we set the process up to be end to end and standard single use things and.

46
00:05:47,900 --> 00:05:55,210
Whip it, and if I'm frank in large part because we need to make it quite simple so the CBF could execute it.

47
00:05:55,220 --> 00:06:04,310
We kept a very simple way, avoided doing, you know, some things which might have made more vaccine or better and sexier,

48
00:06:04,310 --> 00:06:08,630
but we compromised on something to keep it simple.

49
00:06:11,540 --> 00:06:24,470
So the CBF had successfully run that process and made enough vaccine for a few thousand doses in I think 2019 for our rabies vaccine.

50
00:06:26,210 --> 00:06:34,200
And subsequently I have been a co-investigator on a large grant,

51
00:06:35,170 --> 00:06:40,760
the Oxford part of which was what was led by us on Sara Gilbert called the future vaccine manufacturing research job.

52
00:06:41,010 --> 00:06:47,360
Yeah, and that was really, really important.

53
00:06:49,070 --> 00:06:53,450
So tell me a bit about them, and I think that is important. So how did that help come to be?

54
00:06:53,510 --> 00:07:00,920
So that started in 2017. I think I'm right in saying that something like didn't write it down, but yeah, something like that.

55
00:07:01,190 --> 00:07:05,090
So I mean, why does that seem to be necessary?

56
00:07:07,470 --> 00:07:13,590
So to be honest, I don't know the the sort of political background to it in great detail.

57
00:07:13,980 --> 00:07:17,460
But around that time the the was.

58
00:07:19,200 --> 00:07:24,900
Significant investment public funds in vaccine manufacturing.

59
00:07:25,560 --> 00:07:35,400
And two things. One, one was the set up of the Vaccine Manufacturing Innovation Centre or the MCC, which was going to be built in Holywell.

60
00:07:36,150 --> 00:07:38,370
And we should probably come back to that.

61
00:07:39,870 --> 00:07:47,640
But that was a £67 million investment of public funds to build the facility, you know, bricks of bricks and mortar and bus largely.

62
00:07:49,680 --> 00:07:57,630
And the second was investment of about £17 million in these two vaccine manufacturing research hubs.

63
00:07:58,350 --> 00:08:04,350
So the had one being at UCL. So there was one at Imperial.

64
00:08:04,350 --> 00:08:12,510
Imperial, and there was one of the one we're involved in is actually technically led by UCL because it was an imperial one and a UCL, Oxford one.

65
00:08:17,130 --> 00:08:29,880
So my understanding is that those things were driven by something called the UK Vaccines Network, which I think Chris Whitty may have led.

66
00:08:29,880 --> 00:08:35,460
But I think others of my colleagues would be able to give you the history of more pumps.

67
00:08:35,610 --> 00:08:47,640
Adrian Hill And I know Sara Gilbert was involved and so anyway, there's this future vaccine manufacturing research Hall,

68
00:08:48,630 --> 00:08:54,840
Oxford in UCL, I think about seven and a half million pounds and.

69
00:08:57,040 --> 00:09:05,590
There were four strands of work being done in Oxford, some of which I ended up doing two,

70
00:09:07,270 --> 00:09:13,120
essentially because they matched what I'd been doing on the rabies programme. So one of them was to continue to develop.

71
00:09:14,220 --> 00:09:20,850
Better ways of making on the horse vectors. And the other was better ways of making them temperature stable.

72
00:09:22,410 --> 00:09:30,850
And. It's probably worth mentioning that that funding was, I believe, overseas development aid funding,

73
00:09:31,270 --> 00:09:42,970
and it was very much targeted development in developing manufacturing methods that would be suitable for vaccine production in developing countries,

74
00:09:45,910 --> 00:09:46,840
which is what we did.

75
00:09:47,290 --> 00:10:01,179
And I think that probably is one of the best investments the UK has ever made, perhaps in terms of both benefit for low and middle income countries.

76
00:10:01,180 --> 00:10:08,860
LMI sees benefit for the UK itself because if we hadn't had that funding, we would not have an oxford-astrazeneca vaccine.

77
00:10:11,020 --> 00:10:17,140
So the reason I say that is that we had.

78
00:10:18,460 --> 00:10:28,960
I think I think the future vaccine manufacturing research I only really got on the way and in 20 know those parts were all I'd had

79
00:10:28,960 --> 00:10:35,980
one postdoc working on it it was called Sophia Fellowship and she so she had finished off what we'd started doing for rabies,

80
00:10:35,990 --> 00:10:39,770
the basic first version of our manufacturing process.

81
00:10:40,300 --> 00:10:44,320
Finished off in 2018, early 2019.

82
00:10:44,330 --> 00:10:47,200
What was the first bits of what we did in The Hub?

83
00:10:47,740 --> 00:10:56,380
And then Sophie, I wanted to move on to something else, and I hired a new post-doc who's called Carina Jo.

84
00:10:57,790 --> 00:11:04,090
She's Indonesian. She just finished a PhD in Australia and I.

85
00:11:05,930 --> 00:11:13,610
Felt that what we should focus on to improve our manufacturing process was the what's called the upstream process,

86
00:11:13,610 --> 00:11:19,460
which is how much vaccine is made by the cells that are making them making the vaccine virus.

87
00:11:21,620 --> 00:11:26,330
The the other bit, the downstream process, which is how you purify the virus away.

88
00:11:26,900 --> 00:11:32,330
I thought what we had was was okay and actually what was limiting how much we could get was the upstream.

89
00:11:33,800 --> 00:11:40,660
So I went looking for a postdoc with the relevant experience to do that.

90
00:11:40,760 --> 00:11:50,239
And Carina had quite a bit of experience in culturing mammalian cells,

91
00:11:50,240 --> 00:11:58,400
the type of cells we used to make the vaccine in a sort of industrial biotechnology type setting.

92
00:12:00,110 --> 00:12:05,330
And so she arrived in, I think, August 2019.

93
00:12:05,780 --> 00:12:16,099
And more or less the first experiment she ever did was to try some different culture media with the cells,

94
00:12:16,100 --> 00:12:19,340
which we'd always used, quite old culture media.

95
00:12:20,840 --> 00:12:24,930
And she said all these various more modern ones, we should we should try.

96
00:12:24,950 --> 00:12:27,139
And to be honest, I was a bit doubtful about it.

97
00:12:27,140 --> 00:12:37,100
I wanted, but I thought probably we'd get better results by doing it the way that Johnson and Johnson make that happen,

98
00:12:37,100 --> 00:12:40,740
of course, vectored vaccines, which is using a much more complicated technique called perfusion.

99
00:12:43,130 --> 00:12:47,960
But Carina said was, let's try this new modern medium.

100
00:12:48,620 --> 00:12:56,390
And she did it. And she brought me the results in, I think late November or early December 2019.

101
00:12:56,720 --> 00:13:00,770
And they were really good. I didn't really believe they were so good.

102
00:13:00,770 --> 00:13:08,419
I didn't really believe they could be real. So it was less replicate, less repeat the experiments.

103
00:13:08,420 --> 00:13:20,360
She went away. Not a all. I came back in January and she brought me the the repeat data and I think late January or early February.

104
00:13:20,360 --> 00:13:25,860
And it was just as good. So what was the medium?

105
00:13:26,250 --> 00:13:30,900
It was simply making making cells grow faster, reproduce more quickly,

106
00:13:30,930 --> 00:13:37,950
making the cells happier at a higher density as well, and ensure it was what it was doing.

107
00:13:38,160 --> 00:13:46,590
So the. The, you know, dogma in the field about the virus.

108
00:13:47,280 --> 00:13:52,290
Vaccine manufacturing for a long time has been at a certain level of cell density.

109
00:13:52,500 --> 00:13:56,000
The cells stopped making the vaccine efficiently.

110
00:13:56,160 --> 00:14:00,350
And it's not just not just dogma. There's lots of evidence to show that was the case and that was what I was doubtful for.

111
00:14:00,590 --> 00:14:11,790
It would work. But it turned out that it hasn't been done a lot believe hadn't been sort of retested since all of the media had been developed.

112
00:14:13,200 --> 00:14:18,110
So. We got pretty lucky, to be honest.

113
00:14:18,440 --> 00:14:22,070
You know, incredibly lucky. The thing that worked.

114
00:14:23,660 --> 00:14:34,270
And so. What they enables is what's called a Fed balance process,

115
00:14:35,050 --> 00:14:44,590
which is essentially the plain vanilla of the global biopharmaceutical manufacturing industry.

116
00:14:45,580 --> 00:14:53,320
It's very similar to the way that monoclonal antibodies, which, you know, the most common biopharma group of products in the world,

117
00:14:54,160 --> 00:14:59,800
are made and you just put cells into a big part of either reactor and you grow them.

118
00:15:00,640 --> 00:15:10,330
You add some extra supplements to keep them happy when they get tired and sitting and you take out your products at the end and it's much more

119
00:15:10,510 --> 00:15:17,350
is much simpler than the alternative way of making out the virus in a large scale would have been regarded as the industrial gold standard,

120
00:15:18,110 --> 00:15:27,939
which was the fusion which JNJ had developed, JNJ had been working on on Novartis manufacturing for a change,

121
00:15:27,940 --> 00:15:31,990
and companies they had bought have been working on manufacturing since the nineties.

122
00:15:32,890 --> 00:15:37,360
I had it really fantastically, you know, brilliant process, you know, very, very elegant.

123
00:15:37,360 --> 00:15:40,940
Good. They've done great work on it, but.

124
00:15:42,270 --> 00:15:47,820
You know, I don't think they've been developing it. And nobody nobody had been developing a process on it.

125
00:15:48,000 --> 00:15:57,000
If we're honest for something, the scale of the pandemic and change process was relatively complicated.

126
00:15:58,530 --> 00:16:04,780
So in that sort of brings us to early February 2020.

127
00:16:05,580 --> 00:16:09,330
Right. By which time. And we already knew it.

128
00:16:09,330 --> 00:16:18,210
So it would be just I'm always just asking everybody this question. Can you remember when you first heard that there was a pandemic in the offing?

129
00:16:19,620 --> 00:16:27,870
I can't remember the very first time I ever heard about the virus, but I was certainly aware of it in January.

130
00:16:29,550 --> 00:16:38,220
And I can remember having a conversation with Sara Gilbert and just in passing in the office and Jan saying, Oh,

131
00:16:38,220 --> 00:16:44,340
you know, there's this virus in and in Wuhan and you're making any vaccine, you know, because I was there as remote.

132
00:16:46,260 --> 00:16:53,250
And I if I'm honest, I had never been very honest, very, very been very honest.

133
00:16:53,430 --> 00:16:57,150
I'd never been very interested in you know, it was it wasn't my thing.

134
00:16:57,180 --> 00:17:02,340
Emergent pathogens and outbreaks. And I was.

135
00:17:04,210 --> 00:17:07,870
I have been during the Ebola pandemic, for example.

136
00:17:07,870 --> 00:17:12,030
I had been quite. Sceptical.

137
00:17:12,050 --> 00:17:16,760
You know, there have been lots of Ebola outbreaks and it has not caused a pandemic.

138
00:17:17,120 --> 00:17:23,839
You know, we we I think a lot of the things which people are worried about,

139
00:17:23,840 --> 00:17:30,390
or at least in the media, there's been concern about epidemics that actually have fizzled out.

140
00:17:30,620 --> 00:17:36,859
And they've been proven to be viruses that maybe didn't have the potential for for causing such serious problems.

141
00:17:36,860 --> 00:17:44,090
And that's not not to say that I didn't regard a pandemic from some virus as an existential threat.

142
00:17:44,870 --> 00:17:53,870
I had had a clinical tutor in in medical school, Alan Townsend, who I remember impressed on me.

143
00:17:53,870 --> 00:17:56,860
Very, very. You know, it really stuck in my mind.

144
00:17:56,870 --> 00:18:04,220
He was viscerally scared about the potential for a flu pandemic and how that would overwhelm the NHS.

145
00:18:05,150 --> 00:18:08,540
I'm not really stuck with that, but I.

146
00:18:10,150 --> 00:18:18,190
My sort of prior belief hearing about this virus in Wuhan was that it would probably fizzle out like we talked about before.

147
00:18:19,120 --> 00:18:24,820
And so that initial conversation was there. It was on. I don't think either of us really thought it was going.

148
00:18:25,180 --> 00:18:31,580
You know, she was working on it because I'm sort of thing. But I don't think either of us really thought it was a serious.

149
00:18:31,630 --> 00:18:35,020
It was. What changed that for me?

150
00:18:35,920 --> 00:18:40,719
I read an article in the New York Times on the 2nd of February.

151
00:18:40,720 --> 00:18:43,720
I don't know what pulled the graph. The really.

152
00:18:45,020 --> 00:18:58,520
Got me scared. I pulled the graph out of it and I got a slide showing up and it was a graph of the R value of all on those

153
00:18:58,520 --> 00:19:05,120
with no values versus the infection fatality rate percentage of people who would die after getting infected.

154
00:19:05,840 --> 00:19:17,239
I showed the estimate for became SARS-CoV-2 you know with wide ranges of uncertainty on both of those based on the early data

155
00:19:17,240 --> 00:19:28,970
from China and it showed by comparison those those numbers for the original songs and for Mars and for Ebola and for flu and.

156
00:19:30,430 --> 00:19:43,740
It was very apparent for that from the plausible ranges of R an inflection of style fatality rates included at the centre of the range,

157
00:19:43,820 --> 00:19:45,639
the most likely number,

158
00:19:45,640 --> 00:19:53,770
but certainly the less favourable ones as well, included things which were very, very, very scary and worse than anything the world had seen.

159
00:19:55,600 --> 00:20:02,410
And. You know, worse than, you know, any flu pandemic in living memory.

160
00:20:04,320 --> 00:20:09,610
And. To me, that was all that was needed to.

161
00:20:14,810 --> 00:20:19,090
It became like my little brother.

162
00:20:20,440 --> 00:20:24,880
And, you know, it was apparent from the.

163
00:20:25,860 --> 00:20:28,890
This was something the world needed to take very, very seriously.

164
00:20:31,620 --> 00:20:38,230
And. If I'm honest, I'm uncertain how.

165
00:20:43,220 --> 00:20:47,630
Governments were not on maximum alert at that point.

166
00:20:47,660 --> 00:20:57,740
I think there was sufficient data in early February in The New York Times to merit, you know, treating this as a huge, huge global emergency.

167
00:20:59,720 --> 00:21:08,810
And I wasn't sure what to do for a few days because it wasn't my area of research.

168
00:21:09,120 --> 00:21:14,660
I realised then that actually it didn't take very long to sort of, you know,

169
00:21:14,680 --> 00:21:23,120
I the chimpanzee adenovirus platform we have here, we've used it for literally hundreds of things in preclinical work.

170
00:21:23,120 --> 00:21:27,290
And, you know, it's, it's, it's simply molecular based.

171
00:21:27,380 --> 00:21:36,890
You can put a new antigen from whatever pathogen you like, put a new antigen into it, and you can get an immune response.

172
00:21:37,820 --> 00:21:48,710
It's very simple. And I knew, you know, whichever whichever antigen we done and I think there have been ten or 12 of them in clinical trials.

173
00:21:50,510 --> 00:22:00,070
It's safe and you got an immune response. And I knew also that Sarah had done nothing worse.

174
00:22:01,490 --> 00:22:05,180
And that was protective in monkeys.

175
00:22:05,850 --> 00:22:13,550
I got an immune response and people and I knew also that for Ebola vaccines,

176
00:22:15,140 --> 00:22:23,750
it actually proved there's a big, huge question of how was it going to be possible to make a vaccine?

177
00:22:25,180 --> 00:22:31,590
That was that was critically important. And in February of 2020, in deciding what should be done, you know,

178
00:22:32,190 --> 00:22:38,510
how likely it was that a vaccine could be developed quickly enough to make it worth doing lockdown, for example.

179
00:22:38,550 --> 00:22:42,510
So there's no point looking down if everyone's going to get it anyway.

180
00:22:42,840 --> 00:22:46,450
It has to be on an accelerated. And.

181
00:22:48,210 --> 00:22:52,290
On you, for example, in. For Ebola.

182
00:22:56,560 --> 00:23:00,670
That being really the opposite experience for HIV.

183
00:23:00,710 --> 00:23:06,520
You know, some some some diseases. It's very hard to make a vaccine against HIV, for example.

184
00:23:06,520 --> 00:23:12,220
There's umpteen different ways of protecting a monkey. But it's nobody's got an effective HIV vaccine for people.

185
00:23:13,690 --> 00:23:19,720
But the experience for Ebola have been the reverse. It was relatively challenging to protect monkeys.

186
00:23:20,170 --> 00:23:29,080
But then when Ebola vaccines actually deployed in West Africa, more or less anything, you know, it wasn't that hard to protect.

187
00:23:29,860 --> 00:23:35,440
And the reason for that was that the the animal challenge model was very, very stringent.

188
00:23:36,970 --> 00:23:41,120
I don't know how true this is, but some someone someone told me the animal challenge model was, you know,

189
00:23:41,140 --> 00:23:49,570
developed for bioterrorism purposes, you know, to to mimic, you know, a baseball stadium being sprayed with Ebola in huge quantities.

190
00:23:51,610 --> 00:23:56,980
Whereas in reality, in the in the real world, if you're exposed, you, you know, you're exposed to very tiny amounts of that.

191
00:23:57,160 --> 00:24:01,690
So it was actually actually pretty easier to protect people and.

192
00:24:04,170 --> 00:24:10,710
For, you know, generally speaking for acute infections, which.

193
00:24:14,290 --> 00:24:18,369
You know, the natural history of infection is that it resolves you know,

194
00:24:18,370 --> 00:24:22,600
the normal outcome of infection is that people develop immunity and they get better.

195
00:24:23,020 --> 00:24:30,250
And we you know, we knew that was going to happen, that 90 plus percent of people that got this infection for that.

196
00:24:30,820 --> 00:24:35,170
All you're trying to do with a vaccine is emulate what natural infection does.

197
00:24:35,830 --> 00:24:38,020
And that's not hard to do.

198
00:24:40,470 --> 00:24:47,160
There's obviously lots of complications and reasons that might prove problematic, but fundamentally, a lot can usually be done.

199
00:24:48,030 --> 00:24:54,540
And it's fundamentally different from something like HIV, where the natural immune response doesn't protect.

200
00:24:55,200 --> 00:25:04,980
So my feeling in February 2020 was that the technology platform we had had a very good chance of being effective.

201
00:25:07,130 --> 00:25:09,590
I wouldn't put a percentage on that, but, you know,

202
00:25:09,590 --> 00:25:16,460
I would have I would certainly have taken a bet of 5050 having some effect against severe disease and death.

203
00:25:19,990 --> 00:25:29,920
And the real problem, you know, I knew there the vaccine had already been made by the you know, we already had it.

204
00:25:30,640 --> 00:25:34,540
So the challenge is, how did you get it out of the lab and into the real world?

205
00:25:36,220 --> 00:25:43,490
And I actually would probably personally in a world with no vaccine regulation.

206
00:25:45,590 --> 00:25:53,880
And an uncontrolled pandemic. Personally as a as a well and, you know, relatively well informed person was there.

207
00:25:53,890 --> 00:26:00,130
I would probably have taken the vaccine blind in February or March 2020.

208
00:26:00,670 --> 00:26:10,149
I would have been confident, with no evidence that the the risk benefit balance of having had the, you know, no new evidence specific plant vaccine.

209
00:26:10,150 --> 00:26:14,620
But what I know about the virus vaccines before and vaccines against all the coronaviruses,

210
00:26:15,340 --> 00:26:20,560
I would have been convinced that the risk benefit balance of having some of the vaccine made in the lab,

211
00:26:20,740 --> 00:26:28,480
you know, was that the manufacturing standards that we apply in the lab, that would have been more beneficial and risky to me.

212
00:26:29,200 --> 00:26:36,310
But that's clearly not how things work for and shouldn't be, how things work for, for deploying vaccines for these millions of people.

213
00:26:37,390 --> 00:26:41,290
So the real the real challenge is, is not making the vaccine.

214
00:26:41,950 --> 00:26:50,410
It's, you know, the groundwork on making the vaccine to create the technology platform not been done over the preceding ten years.

215
00:26:50,770 --> 00:27:01,870
You know, that was hard, but it wasn't hard in February 2020 was hard in February 2020 was how to do a rapid clinical trial and.

216
00:27:03,460 --> 00:27:07,510
Actually even that I felt might be very, very fast.

217
00:27:08,260 --> 00:27:17,980
We had a sort of slightly skipping ahead, but we had an extraordinary meeting in early March 2020 when we were designing the Phase one clinical trial,

218
00:27:18,910 --> 00:27:24,520
and we were designing the Phase one trial, which was, you know, the idea was to vaccinate something like 40 people.

219
00:27:27,250 --> 00:27:31,180
We normally for a phase one trial with small numbers like that, we don't do controls.

220
00:27:32,290 --> 00:27:37,359
We don't give people placebo because you're just looking for safety.

221
00:27:37,360 --> 00:27:45,190
And then in response, yeah, and you measure an immune response and it's not possible in a phase one to measure efficacy against infection.

222
00:27:46,060 --> 00:27:54,879
But we have this extraordinary experience of designing a Phase one trial with with controls and thinking, well, it was quite possible.

223
00:27:54,880 --> 00:28:02,140
And the government wasn't looking down at that point that if we vaccinated people in April, you know,

224
00:28:02,560 --> 00:28:08,290
20, 30% of the people in the trial might be exposed to the virus in the course of a couple of months.

225
00:28:08,740 --> 00:28:14,740
And actually, statistically, that would be sufficient to give an efficacy rate on those tiny numbers.

226
00:28:16,780 --> 00:28:21,820
So the. It was.

227
00:28:23,230 --> 00:28:28,330
I felt that because we had the prior safety experience on and given the similar,

228
00:28:28,330 --> 00:28:35,380
very similar vaccines to lots of people because the clinical need was huge.

229
00:28:35,470 --> 00:28:41,560
You know, if you've got a 10% risk of dying, if you're an older person and you've got this this virus, you know,

230
00:28:41,570 --> 00:28:48,910
how much safety data do you need to know to know that some protection from a vaccine is better than whatever the risk is from a vaccine?

231
00:28:49,000 --> 00:28:55,420
You know, if the stakes are very, very high in terms of risk of the infection, you know,

232
00:28:55,420 --> 00:29:01,450
if you've got if you've given the given the vaccine 2000 people and followed them up for a month,

233
00:29:02,470 --> 00:29:10,150
and, you know that, you know, you're, you know, considering vaccinating a population with a 10% risk of death if they get an infection.

234
00:29:10,810 --> 00:29:13,120
Well, actually, that's probably sufficient safety data.

235
00:29:14,080 --> 00:29:23,020
So it seemed in this very unusual context that it might be possible to provide adequate data to motivate,

236
00:29:23,110 --> 00:29:29,410
you know, adequate data to support deploying the vaccine in high risk populations,

237
00:29:30,160 --> 00:29:36,580
you know, health care workers very, very rapidly, because both safety, you know,

238
00:29:36,580 --> 00:29:41,950
we knew the platform was fairly safe and we might get an efficacy result very, very quickly.

239
00:29:42,070 --> 00:29:46,840
At the speed with which we got an efficacy result was a function essentially of how quickly

240
00:29:46,840 --> 00:29:53,440
we could get people vaccinated and how many cases of the virus there were in the population.

241
00:29:55,360 --> 00:29:59,440
The only reason we didn't get an efficacy result sooner was because of lockdown.

242
00:29:59,830 --> 00:30:04,570
Yeah. So this wasn't enough circulating infection and I.

243
00:30:06,050 --> 00:30:09,270
Talk about a bit more about lockdown in a minute maybe.

244
00:30:10,220 --> 00:30:17,900
Clearly, it was good that it happened, but we would have had an efficacy results and in summer 2020,

245
00:30:18,890 --> 00:30:21,340
had there been a large wave of infection on lockdown.

246
00:30:22,580 --> 00:30:35,480
So I felt like in February 2020 that, you know, technologically, the button Oxford's vaccine technology was getting off target crocodiles.

247
00:30:36,740 --> 00:30:44,180
I knew that the university was Andy Card in particular experience of running large trials during

248
00:30:44,180 --> 00:30:50,820
the swine flu pandemic university and the clinical trial capability to to run trials quickly.

249
00:30:50,840 --> 00:30:56,600
You know, if the journal is good at anything, it's good at getting things into people quickly and efficiently.

250
00:30:57,950 --> 00:31:03,319
The general run, the fastest phase one trial in the world for an Ebola vaccine candidate.

251
00:31:03,320 --> 00:31:07,540
Didn't develop like the vaccine in that case, but.

252
00:31:08,920 --> 00:31:10,930
We're quite good at getting things done quickly.

253
00:31:11,000 --> 00:31:18,540
The UK regulators are very effective as well in getting things turned around fast in an emergency like London,

254
00:31:19,510 --> 00:31:27,820
and I thought it would be possible to progress very rapidly from a phase one into thousands of people.

255
00:31:29,260 --> 00:31:33,940
So I thought the technology in the clinical trial actually probably wasn't that problematic.

256
00:31:34,020 --> 00:31:38,739
They were they weren't going to be the rate limiting thing and getting vaccine out into the world,

257
00:31:38,740 --> 00:31:42,639
the right limiting thing and actually potentially a fatal flaw for universities

258
00:31:42,640 --> 00:31:47,380
programme as a whole was the fact that we had no idea how to manufacture a large scale.

259
00:31:47,980 --> 00:31:57,580
You know, we if you'd asked me what's going to happen in, in, in February 2018, if in February 2020 you'd asked me what's going to happen,

260
00:31:58,870 --> 00:32:02,919
I'd have said I thought probably the most likely scenario or quite unlikely

261
00:32:02,920 --> 00:32:09,010
scenario would be that we might find out in summer that the vaccine worked,

262
00:32:09,700 --> 00:32:15,370
but we wouldn't have any of it to give to anyone what happens in normal times?

263
00:32:16,430 --> 00:32:24,190
How would you normally get a vaccine scaled up for something like like no childhood diseases or one of those?

264
00:32:25,750 --> 00:32:31,659
So what would happen normally is that you would do a phase one trial and then you would stop and

265
00:32:31,660 --> 00:32:35,890
you would look at the results from the phase one trial in a few tens or maybe a hundred people.

266
00:32:36,700 --> 00:32:40,540
And if not looked okay, then you'd do a phase two trial, a couple of hundred people.

267
00:32:41,710 --> 00:32:47,440
And often those are done with only small scale manufacturing capability.

268
00:32:48,400 --> 00:32:55,390
And then in industry, you know, phase three trial is relatively unusual for phase three trials to be done in academia,

269
00:32:55,420 --> 00:32:59,620
or at least unusual to be done by academics without an industrial partner.

270
00:33:03,640 --> 00:33:07,170
Typically what happens is that a phase three trial will happen,

271
00:33:07,900 --> 00:33:17,450
that a large scale manufacturing process will be developed to produce the vaccine for the phase three trial by the commercial partner usually, yes.

272
00:33:17,470 --> 00:33:17,800
Yeah.

273
00:33:18,670 --> 00:33:34,450
And it you know, I can't think of an example of a phase three trial, you know, happening with public funding, with academically manufactured vaccine.

274
00:33:34,450 --> 00:33:45,250
When I in it, you know, the Norway's an industrial partner and the idea there is that, you know, a,

275
00:33:45,610 --> 00:33:51,490
you know, phase three trial is going to cost depending on who you believe, at least tens of millions.

276
00:33:53,560 --> 00:33:59,320
And you should, you know, to no point investing in it's not going to be possible to make it at scale.

277
00:34:02,080 --> 00:34:11,740
B, if you do the trial and then you change the manufacturing afterwards, then you have a comparability.

278
00:34:11,770 --> 00:34:15,820
People get very worried about comparability when manufacturing processes change.

279
00:34:16,090 --> 00:34:20,049
How do you know that what's coming out of the new manufacturing process is exactly

280
00:34:20,050 --> 00:34:23,500
the same as the the vaccine that gave the good results in the clinical trial?

281
00:34:24,250 --> 00:34:32,500
So people like to have the final process pinned down for phase three and but then actual investment

282
00:34:32,500 --> 00:34:40,480
in really making millions and millions of doses would only happen after the phase three.

283
00:34:41,330 --> 00:34:46,990
The result? Sometimes people would invite you if they were confident.

284
00:34:47,800 --> 00:34:54,230
A company was confident. I think they might invest in actually building a new factory in parallel with a phase three trial.

285
00:34:56,270 --> 00:35:01,700
But you certainly wouldn't be churning out millions of doses during the phase three trial.

286
00:35:03,170 --> 00:35:06,350
So that's the usual way of things. And.

287
00:35:09,630 --> 00:35:13,980
That clearly wasn't going to work in this case.

288
00:35:15,270 --> 00:35:19,110
On the other, things about the usual way of things is incredibly slow.

289
00:35:20,070 --> 00:35:28,140
So pharmaceutical manufacturing happens on to this GMP, good manufacturing process regulation.

290
00:35:29,400 --> 00:35:39,510
And there's a deeply ingrained culture of quality and quality to you and me might mean,

291
00:35:39,900 --> 00:35:43,380
you know, something as good something as fit for the purpose for which it's intended.

292
00:35:44,400 --> 00:35:48,630
But in that environment, I think this is what a lot of people would rightly expect.

293
00:35:49,050 --> 00:35:52,830
It's a very, very risk averse environment. And.

294
00:35:54,370 --> 00:35:58,299
For me, coming from a clinical background, I sometimes find that quite challenging.

295
00:35:58,300 --> 00:36:10,480
The I, the there's very high value placed on avoiding any potential risk arising from a manufacturing problem and.

296
00:36:12,040 --> 00:36:16,209
Less value placed on the home.

297
00:36:16,210 --> 00:36:28,070
The results if making. The manufacturing so controlled actually makes it so expensive and slow that no drug gets to

298
00:36:28,070 --> 00:36:36,500
patients or it's impossible to develop the drug or it gets to patients years later in it.

299
00:36:36,670 --> 00:36:44,540
In a clinical medical context, you accept that for every everything you prescribe to a patient, all the risks and benefits.

300
00:36:46,640 --> 00:36:53,960
It's not a zero risk culture, but the culture and in biopharmaceutical manufacturing is.

301
00:36:57,000 --> 00:37:02,130
Close to being a zero risk culture. I love that because of a fear of litigation.

302
00:37:03,360 --> 00:37:03,959
Yes.

303
00:37:03,960 --> 00:37:12,960
And I think also, you know, there's a basic feeling people should know, you know, nobody should die because of a defective vaccine, the 21st century.

304
00:37:13,410 --> 00:37:27,990
You know, that is an unacceptable thing. My personal feeling is that the.

305
00:37:29,640 --> 00:37:35,010
Aspects of that culture of quality and risk aversion are.

306
00:37:37,910 --> 00:37:45,680
Far more onerous than is proportionate to the actual true risk.

307
00:37:46,790 --> 00:37:56,900
And that, you know, and that's because the culture is dominated by manufacturing specialists and not not by clinicians who think about,

308
00:37:57,200 --> 00:38:05,240
you know, what is a real risk to a person. So the relevance of this to COVID 19 is that the.

309
00:38:07,330 --> 00:38:10,780
That expectation of.

310
00:38:12,600 --> 00:38:14,610
Extremely controlled,

311
00:38:15,210 --> 00:38:25,110
extremely well understood manufacturing processes and no change in those manufacturing processes between a Phase three trial and.

312
00:38:28,000 --> 00:38:33,240
And deployment of a vaccine. Makes it incredibly slow.

313
00:38:34,540 --> 00:38:41,440
To develop new products. And actually looking in February 2020 that.

314
00:38:43,480 --> 00:38:48,010
It seemed to me that the speed with which the manufacturing could be scaled up,

315
00:38:48,520 --> 00:38:55,239
both from the point of view of doing it in a regulatory compliant way and from the from a financial perspective,

316
00:38:55,240 --> 00:39:01,780
the fact that, you know, if you want to make a vaccine and you don't have your own factory,

317
00:39:02,560 --> 00:39:09,190
you need to invest millions of pounds in booking a facility upfront.

318
00:39:10,150 --> 00:39:17,860
And we didn't have millions of pounds. And, you know, it takes months and months to prepare the facility to do the first batch.

319
00:39:19,810 --> 00:39:29,670
I use the analogy with people. It you know, it's a little bit like setting up a new branch of McDonald's or something.

320
00:39:29,680 --> 00:39:35,660
You know, it might take months and months to prepare the facility trains, train the staff and,

321
00:39:36,490 --> 00:39:40,000
you know, invent the recipe if you're inventing hamburgers for the first time.

322
00:39:40,900 --> 00:39:44,890
But once you've got it, you can churn out the vaccine very quickly and.

323
00:39:46,920 --> 00:39:53,190
I was concerned that that set up was not going to happen soon and often.

324
00:39:53,370 --> 00:40:01,260
And I hadn't. I felt it had to be done before we knew, before we had evidence whether all the vaccine was going to work.

325
00:40:02,310 --> 00:40:13,980
So really, within a few days of that reading, that New York Times article, having sort of torn my hair out for a battle,

326
00:40:14,130 --> 00:40:17,970
I remember writing to the Guardian neighbours and saying, Do you want it?

327
00:40:18,000 --> 00:40:23,550
Would you be interested in a piece from the vaccine developer about how to regulate?

328
00:40:24,260 --> 00:40:31,169
Quite a lot of pinch, though I felt there was a problem of awareness that actually it would be possible to make a vaccine.

329
00:40:31,170 --> 00:40:34,460
But the challenges were around regulation, manufacturing.

330
00:40:34,760 --> 00:40:42,420
But I wasn't part of the programme here and I thought it was important people understood that.

331
00:40:43,290 --> 00:40:46,930
The Guardian, unsurprisingly, were not interested in what I had to say.

332
00:40:49,560 --> 00:40:59,220
But I realised that actually all of the people in Oxford who might be able to do something about this problem.

333
00:40:59,550 --> 00:41:05,430
Well, really, I was the only person who had worked on scalable manufacturing of this type of vaccine.

334
00:41:07,990 --> 00:41:13,000
And so I started thinking, you know, what can we do?

335
00:41:13,690 --> 00:41:19,990
And with Katrina's result or coroner's results show it was that we could get.

336
00:41:22,430 --> 00:41:29,120
More vaccine from a very simple process than had previously been thought possible.

337
00:41:30,710 --> 00:41:45,380
And with that, it seemed like it would be not that hard in a sort of purely technical sense, but very, very hard.

338
00:41:45,380 --> 00:41:53,959
And that's been in a sort of GMP compliance sense, unheard of in a GMP compliance sense, technically possible, but regulated,

339
00:41:53,960 --> 00:42:00,740
really challenging to take what we had at the scale of, you know, literally two tablespoons, 30 millilitres was the scale.

340
00:42:01,070 --> 00:42:08,840
Kareena had got her original results. It seemed to be possible to turn that into a commercial scale process, which would be 200 litres.

341
00:42:09,620 --> 00:42:11,600
And on what kind of time scale?

342
00:42:12,860 --> 00:42:23,660
Well, in fact, in February 2020, I started putting together a grant proposal in the UK or I had a UK government research funding,

343
00:42:24,170 --> 00:42:37,219
how to do emergency COVID funding. So I put in a grant and got 2 million for the Phase one trial and I missed the first deadline known to exist.

344
00:42:37,220 --> 00:42:52,450
And I wasn't ready. I put but essentially I put together an application for £400,000 to and the pitch was enabling production of the titles,

345
00:42:52,490 --> 00:42:59,060
enabling production of a million doses by the end of 2021 to vaccinate NHS workers.

346
00:43:00,230 --> 00:43:05,640
That was, that was, you know, that seemed like a wildly ambitious, you know,

347
00:43:05,660 --> 00:43:10,070
no one really was thinking, well, a million doses might be available within 2020.

348
00:43:11,940 --> 00:43:17,800
And we knew, we knew we couldn't do that internally.

349
00:43:17,810 --> 00:43:31,070
So to enable putting together the proposal, I had reached out to the Vaccine Manufacturing Innovation Centre directly.

350
00:43:31,130 --> 00:43:35,660
So that was something that at that point, V-neck was no building.

351
00:43:35,960 --> 00:43:44,990
I was six people in an office on the science park with some plans for building, but they had one guy called John Humphrys,

352
00:43:44,990 --> 00:43:50,870
who was the head of process development, who was going to be part of process development side.

353
00:43:51,380 --> 00:43:54,530
And you know, this was their remit, this mobile they were set up to do.

354
00:43:54,860 --> 00:44:02,839
So I got in touch with them and the boss put me in touch with John and he then put me

355
00:44:02,840 --> 00:44:07,900
in touch with a Dutch company called Halix as a contract manufacturing organisation.

356
00:44:08,070 --> 00:44:11,960
They'll take all the people's problems and manufacture them. A commercial is coming.

357
00:44:12,570 --> 00:44:17,330
They very, very new and I don't think they really done anything yet in that facility.

358
00:44:19,400 --> 00:44:25,820
So that was one direction in which I reached out to try and, you know, find some friends, you know, get some help.

359
00:44:29,110 --> 00:44:33,020
The other was Cath Green, who runs the CBA,

360
00:44:33,060 --> 00:44:41,250
said she was on this mailing list for the UK Bio Industry Association and she sent a message to say if anyone on the list would help us.

361
00:44:42,870 --> 00:44:48,029
So she sent out a message on my behalf asking for help and the scale up.

362
00:44:48,030 --> 00:45:01,050
And we got a lot of responses very, very amazingly fast and pull by a tag which is a big sort of equipment that's l p,

363
00:45:01,080 --> 00:45:12,870
I think equipment and materials supplier multinational but with a base in Portsmouth legal all mainly and they said,

364
00:45:12,870 --> 00:45:25,860
well, we'll run it will run a 200 litre barge will will will take your lot process and we'll take it to 200 litre industrial scale and we'll do that.

365
00:45:26,190 --> 00:45:32,210
You know, we'll put in our people's time and, you know, the materials that are up,

366
00:45:32,220 --> 00:45:35,400
you know, pull materials and all the equipment they would supply them.

367
00:45:35,400 --> 00:45:40,890
So it was a big package of in-kind support worth a couple of hundred thousand pounds.

368
00:45:41,760 --> 00:45:45,389
And at that point, you know, really it was an amazing response.

369
00:45:45,390 --> 00:45:54,299
We got via email because at that point the leading UK platform and if you read the papers, the leading UK vaccine programme was, was Imperial.

370
00:45:54,300 --> 00:45:59,640
No one had really heard about as we were. We hadn't nothing, nothing had been put out in the press.

371
00:46:02,700 --> 00:46:06,900
And then one of the other companies that responded that was called Cobra Biologics.

372
00:46:08,580 --> 00:46:12,390
And also I'd made I'd made contact with Oxford Biomedica just down the road.

373
00:46:12,970 --> 00:46:16,320
So I had these conversations.

374
00:46:16,320 --> 00:46:20,850
I remember pacing around the frosty car park in mid-February,

375
00:46:20,850 --> 00:46:25,500
trying to persuade chief scientific officers from these companies I'd never dealt with before,

376
00:46:25,920 --> 00:46:31,409
you know, working at a scale I had no experience of to do this.

377
00:46:31,410 --> 00:46:40,620
Absolutely. What to them was preposterous to take a lab a lab process, couple of tablespoons and turn it into an industrial process with no funding.

378
00:46:42,150 --> 00:46:51,059
Incredibly fast. And Cobra, Biologics and Halix.

379
00:46:51,060 --> 00:46:59,040
The Dutch company came on board for this initial application to UK R.I. and they said they would provide some.

380
00:47:00,520 --> 00:47:10,740
Basically they would prepare to run the process in their facilities, which is a modest investment of that time, but not actually run it.

381
00:47:12,490 --> 00:47:16,990
Oxford, Biomedica at that point decided they weren't able to be involved.

382
00:47:17,620 --> 00:47:24,120
You know, they were much bigger, you know, listed company and they had their own business, you know.

383
00:47:24,130 --> 00:47:30,460
Well, that's out of all the customers needs to me. And they, they weren't able to get involved in the stage, but we kept in touch with them.

384
00:47:32,680 --> 00:47:43,730
And so. Things really how you know what happened very, very fast around the end of February.

385
00:47:43,880 --> 00:47:47,840
Look, you know, within a day or two of speaking to these people,

386
00:47:48,050 --> 00:47:54,980
I put in the application to UK arrived within a day or two of the UK or I phoned back and you know,

387
00:47:55,460 --> 00:47:59,330
they said, you know, we're not we're not officially taking the decisions on these grounds for a while,

388
00:47:59,330 --> 00:48:11,959
but we're going to we're going to fund get on with that. So by the end of February 2020, we were like, well,

389
00:48:11,960 --> 00:48:19,010
we're scaling up as fast as we possibly can towards a but what's called an engineer and basically a process run,

390
00:48:19,550 --> 00:48:24,629
not a clinical grade, but industrially, industrially relevant scale.

391
00:48:24,630 --> 00:48:29,880
And that was going to be done in Paul's facility in Portsmouth. In my lab.

392
00:48:29,880 --> 00:48:39,060
We were all we hadn't done the sort of purification with this, you know, with with vaccine that come from this new media.

393
00:48:39,450 --> 00:48:42,890
All we'd done was we knew we could get a loan from the upstream process.

394
00:48:42,900 --> 00:48:49,770
So in my lab we were frantically checking, well, can we actually still purify the stuff in the way that we had done it before?

395
00:48:50,490 --> 00:48:56,760
How do you in simple terms, how do you purify the product that you want from a very simple time?

396
00:48:56,760 --> 00:49:08,130
And so it's a series of filters, slightly less simple terms of what's called chromatography step, where the virus sticks onto a filter.

397
00:49:08,340 --> 00:49:13,860
Another thing was pass through. So when you say the virus, I think we need to keep clear all the time.

398
00:49:13,860 --> 00:49:20,400
Are we talking about the hot new virus or the spike protein? We're talking about getting the virus for the good question.

399
00:49:20,670 --> 00:49:24,540
Whenever I say the virus in a manufacturing context, I mean the vaccine.

400
00:49:24,660 --> 00:49:34,540
Yeah. Yeah. In the last. Around.

401
00:49:34,540 --> 00:49:42,310
About that time I remember setting up a WhatsApp group with Garth Green and Adam Ritchie, the project manager.

402
00:49:42,940 --> 00:49:46,280
It was called The Coronavirus versus Corona Virus Growth Rate.

403
00:49:46,510 --> 00:49:55,150
Growth Rates Club, you know, and I'd do the logo for the group first set up was to feel a bit of a geeky joke was barely a joke.

404
00:49:55,580 --> 00:50:01,240
It was two intersecting exponential curves. You know, at that point, the corona virus was growing faster.

405
00:50:01,720 --> 00:50:09,490
But what we had to do was try and find a way to make our virus in the virus grow faster, and that should be possible.

406
00:50:09,760 --> 00:50:13,780
You know, I thought the what should be possible. Technically, it was possible.

407
00:50:13,960 --> 00:50:19,240
It was a question of dying in a way that was regulated, fully compliant and financially practical.

408
00:50:21,520 --> 00:50:27,780
So. Three, three Feb 2021.

409
00:50:28,230 --> 00:50:31,890
A plan for getting the manufacturing to, you know, roughly million dollar scale.

410
00:50:33,230 --> 00:50:41,070
I put that together and it looks increasingly like time to plan all the people support in parallel with I was.

411
00:50:43,280 --> 00:50:48,410
Involved in trying it out of us, trying to, you know, motivate.

412
00:50:48,500 --> 00:50:55,250
I felt like I was trying to motivate colleagues within the university to treat this as a real, real emergency.

413
00:50:56,030 --> 00:51:01,520
I remember writing a briefing note for that at an apartment.

414
00:51:04,190 --> 00:51:12,270
In which I said I. Foods. This was potentially the worst emergency for the country since World War Two.

415
00:51:13,770 --> 00:51:21,580
And something that's. It was highly plausible that tens of millions of people would die.

416
00:51:23,440 --> 00:51:32,860
And in February 2020, look, I don't know the case in the UK and a lot of people are still thinking this thing would be contained in China somehow,

417
00:51:33,100 --> 00:51:45,640
despite the big outbreaks in Italy and Iran saw it, the sort of parallel stream of stuff I was doing, which was really trying to.

418
00:51:47,880 --> 00:51:53,070
Persuade people to treat it as a real threat in an emergency.

419
00:51:54,150 --> 00:51:58,830
And I find it quite distressing, to be honest, that there was no.

420
00:51:59,740 --> 00:52:11,800
The prevalent attitude. I was also, you know, at the same time involved in.

421
00:52:13,240 --> 00:52:20,660
Trying to. Well proposals for what we would want, how our clinical development program would work.

422
00:52:20,840 --> 00:52:24,670
So I was speaking with Sara Gilbert and Cascarino.

423
00:52:27,290 --> 00:52:32,770
Adrian Hill was overseas by. Listening to him on the pod wasn't.

424
00:52:34,970 --> 00:52:41,600
Originally involved. A plans to run a paediatric triathlon and later in the summer.

425
00:52:45,730 --> 00:52:54,850
And I put forward this I and the original plan was going to have the first batch of the vaccine made and.

426
00:52:55,970 --> 00:53:04,040
In Italy and a CBF our own manufacturing facility was manufacturing and other products.

427
00:53:04,040 --> 00:53:09,020
It was busy. And I.

428
00:53:10,600 --> 00:53:16,250
Felt quite strongly that the. Manufacturing should stop.

429
00:53:17,120 --> 00:53:25,790
And the quickest way we could make get a clinical trial started was to make it in our own facility, and that could be done within a matter of weeks.

430
00:53:26,840 --> 00:53:35,690
So and I also felt that it was possible to progress the clinical trial plan quite rapidly.

431
00:53:35,900 --> 00:53:53,050
So. On. The first discussion I'm aware of of a continuous phase one, phase two, phase three clinical trial was a.

432
00:53:55,020 --> 00:53:59,820
An email thread started on the 25th of.

433
00:54:00,420 --> 00:54:10,340
February 2020. And things came together for a.

434
00:54:12,840 --> 00:54:17,209
If it felt like critical mass to me, critical mass was achieved.

435
00:54:17,210 --> 00:54:22,450
And this is not. I think it's important to be very clear.

436
00:54:22,760 --> 00:54:27,930
Sarah. Sarah And tests have been working on this from, from January.

437
00:54:28,480 --> 00:54:31,840
Tom Fantastic. Look.

438
00:54:35,020 --> 00:54:44,530
The critical mass around the plan of real emergency clinical development coupled to emergency

439
00:54:44,530 --> 00:54:49,180
manufacturing development to actually get meaningful quantities of it into the real world.

440
00:54:50,020 --> 00:54:55,210
And actually, the connection between the manufacturing and clinical trials was really very important.

441
00:54:55,220 --> 00:54:58,900
You know, we could only do the clinical trials quickly as we can manufacture the vaccine.

442
00:54:59,110 --> 00:55:04,209
So the idea of, you know, really just in time supply, first of all, apart from trial,

443
00:55:04,210 --> 00:55:10,240
kind of go by manufacturing facility building very fast till phase one and then accelerating the

444
00:55:10,240 --> 00:55:18,670
batch from Italy and then maybe whatever we could do it 200 leads scale using one new process the.

445
00:55:20,360 --> 00:55:23,870
The idea we could make that happen and it could feed into a continuous phase one,

446
00:55:23,870 --> 00:55:28,040
two or three trial, and that would then be an industrial scale process.

447
00:55:28,040 --> 00:55:36,790
Ready? And this would be a program that would involve both the General Institute and the Department

448
00:55:36,790 --> 00:55:44,800
of Medicine and also the vaccine group and the Division of Paediatrics that coalesced in a.

449
00:55:46,760 --> 00:56:01,010
For me in a slide presentation to the group of principal investigators from the Department on the 26th February 2020.

450
00:56:02,960 --> 00:56:05,620
And I'm Adrian Holloway.

451
00:56:06,470 --> 00:56:13,970
I asked Richard Cole if we could have the opportunity to present this as the vaccine development team at the start of the meeting.

452
00:56:14,960 --> 00:56:23,410
And Adrian Dalton from Massachusetts Forum in the morning where he was antipolo and came along for the first time,

453
00:56:23,420 --> 00:56:31,070
I think, and they had come to a Department of Medicine meeting relating to the pandemic and.

454
00:56:32,630 --> 00:56:42,500
But all these slides basically said we thought we could open efficacy results and millions of doses of vaccine by the end of the year.

455
00:56:43,860 --> 00:56:46,939
Well, the timeline on the slide was a bit over optimistic.

456
00:56:46,940 --> 00:56:57,810
I think I was leaving for August, but. It was on the call of a figure law.

457
00:57:00,670 --> 00:57:11,950
Amazing. And I remember having a conversation with Crystal Fraser, who's a eminent infectious disease epidemiologist who was in the room.

458
00:57:12,940 --> 00:57:17,330
And he said. Well.

459
00:57:19,380 --> 00:57:24,960
If what you're saying is right, it is possible to make meaningful quantities of vaccine a lot of times.

460
00:57:25,170 --> 00:57:30,870
You know, that sort of timescale, then all the assumptions on which policy is being made.

461
00:57:32,280 --> 00:57:42,660
You know, the decision to not lock down early. Which was, you know, influence my philosophy tone for the most convenient function or any time soon.

462
00:57:43,540 --> 00:57:49,500
He said, Well, you know, people people haven't understood that I could be long seen or be seen on.

463
00:57:50,890 --> 00:57:54,430
If what you're saying is right, then the policy decisions that are being made a roll.

464
00:58:02,860 --> 00:58:06,030
I was. Pretty profound.

465
00:58:06,150 --> 00:58:25,760
Mm hmm. And surely within within the week after that was the first the first meeting of the COVID vaccine programme,

466
00:58:25,970 --> 00:58:32,360
Joint General and Perpetrator Vaccine Group, then planning a phase one trial, you know, huge.

467
00:58:32,360 --> 00:58:37,760
You know, it's absolutely not to an elbow. We were not at all in the frame of infection control.

468
00:58:37,880 --> 00:58:44,540
You know, people were not thinking about how do we, you know, the idea that the virus itself might be a threat to the programme.

469
00:58:47,550 --> 00:58:53,760
Was not there to begin with. It was we were crammed and, you know, 50, 60 people in a tiny room.

470
00:58:55,080 --> 00:59:00,020
And that was quite a discussion about, you know, a phase one that might produce an efficacy result was going on.

471
00:59:00,090 --> 00:59:10,379
I remember saying, you know something someone reminded me in the pub recently that I had said something about everyday.

472
00:59:10,380 --> 00:59:18,150
The everyday slower that we developed a vaccine could be that thousands of people died, which just, you know, it's like great.

473
00:59:18,150 --> 00:59:25,660
You know, sounds grandiose. But I felt it was true.

474
00:59:25,960 --> 00:59:31,420
I thought we had a very serious responsibility to try and move as fast as we possibly could.

475
00:59:32,520 --> 00:59:38,350
I didn't think, you know, early on I thought I vaccine had a good chance of being efficacious.

476
00:59:38,370 --> 00:59:45,540
I didn't I didn't think it would likely turn out to be the best vaccine against COVID 19 in five years time.

477
00:59:46,530 --> 00:59:50,990
But I thought it might be that we were we were able to do it faster.

478
00:59:53,520 --> 00:59:57,120
So for me, speed was the the critical thing.

479
01:00:03,190 --> 01:00:10,509
So yeah, that's the that's the sort of I've been talking for quite a long time.

480
01:00:10,510 --> 01:00:17,110
I've only really brought it up to the end of February 2020. When how is this?

481
01:00:17,110 --> 01:00:20,230
Is this the sort of thing? Yes, yes, absolutely. Absolutely.

482
01:00:20,910 --> 01:00:24,670
It's very much giving us what what it was like to live through it.

483
01:00:24,670 --> 01:00:27,970
I can see it kind of watching it. You are living through it again.

484
01:00:29,140 --> 01:00:34,490
Yeah. So. So once you'd, um. Got that group together.

485
01:00:36,350 --> 01:00:41,100
I mean, you still needed funding, didn't you? Yeah, I know.

486
01:00:41,300 --> 01:00:46,550
But it was a couple of it was a couple of months till before the vaccine taskforce was set up, wasn't it?

487
01:00:46,760 --> 01:00:52,040
Yeah. So for me, February and March 2020 were.

488
01:00:54,500 --> 01:00:59,520
Without a doubt the most intense and distressing. Traumatic.

489
01:01:01,980 --> 01:01:15,080
Period of my life. Because it felt like watching a slow motion train crash on and it was completely avoidable.

490
01:01:16,520 --> 01:01:28,660
Or it felt like it was should be avoidable to a large extent. And you mean in terms of the government not implementing mitigation strategies earlier?

491
01:01:29,230 --> 01:01:33,220
Well, in terms of how the actual work on the vaccine was going.

492
01:01:36,570 --> 01:01:42,190
I think. Partly a bit.

493
01:01:42,270 --> 01:01:47,809
A bit of both. Yeah. I might ask you about it. Not part of the bit that goes online immediately.

494
01:01:47,810 --> 01:01:58,250
I said, well, both of those fell on the vaccine development program, not not just ours, but globally.

495
01:02:00,220 --> 01:02:03,740
Wasn't getting the level of investment. You know, it was.

496
01:02:04,580 --> 01:02:09,170
You know, if you looked at some cost modelling of pandemics, you know, like premiums,

497
01:02:09,170 --> 01:02:16,090
you know what people have done, modelling the cost of a flu pandemic. It was obvious this was going to cost trillions of dollars.

498
01:02:17,740 --> 01:02:23,510
And it was obvious that an effective vaccine would save many billions of dollars.

499
01:02:24,130 --> 01:02:28,600
And we were making decisions for one of lack of 50 or £100,000,

500
01:02:28,600 --> 01:02:33,190
or we were not taking decisions because they would put at risk that sort of money that we did not have.

501
01:02:34,600 --> 01:02:43,360
That could delay things by a couple of weeks. And, you know, I've mentioned in terms of monetary values, but it was also obvious that,

502
01:02:43,510 --> 01:02:47,710
you know, global death rates were probably going to have been thousands of deaths a day.

503
01:02:49,660 --> 01:02:57,390
So. It was terrible and obviously terrible and my own.

504
01:02:58,800 --> 01:03:08,580
I didn't really feel I think a lot of people thought personally I was mad because I was so agitated about it.

505
01:03:12,290 --> 01:03:17,390
I think my own family were worried about me. My father.

506
01:03:18,520 --> 01:03:21,560
Hunt's. Terminal lung cancer.

507
01:03:22,790 --> 01:03:34,099
And he was on chemotherapy. And in February, in February 2020, he decided to go to you know, he's always wanted to see the Sistine Chapel.

508
01:03:34,100 --> 01:03:44,510
He liked art. So I had this, you know, terrible conversation with my parents, first of all, while they were literally on the tarmac at Heathrow.

509
01:03:45,180 --> 01:03:55,800
And then when they'd arrived at the hotel in Rome saying it was a man was immunosuppressed with lung cancer, you should not be in Italy.

510
01:03:56,520 --> 01:04:01,820
I'm really sorry. I know you want to see the Sistine Chapel. But you've got to come home.

511
01:04:04,130 --> 01:04:08,770
And I thought I was mum, but I did come home in the end.

512
01:04:08,780 --> 01:04:12,680
But, you know.

513
01:04:20,440 --> 01:04:31,900
You know, it was a very difficult time. But coming back to the the voting problems, you know, we did not the level of investment we needed.

514
01:04:32,950 --> 01:04:41,980
And, you know, in February, March 2020, the games that the were in town, as it were, for funding was UK RMI,

515
01:04:42,340 --> 01:04:49,530
which had coughed up a couple of million pounds to 2.3 million, I think was a 400,000 for 4 million on the Fox role.

516
01:04:51,150 --> 01:04:54,160
And that was enough to see us through a phase one trial.

517
01:04:55,000 --> 01:05:10,500
There was. Cepi, the Coalition for Epidemic Preparedness Initiatives Innovation, who had previously given Sarah £10 million to work on a mars vaccine.

518
01:05:29,070 --> 01:05:29,370
Yeah.

519
01:05:29,370 --> 01:05:37,140
And Cepi it proved quite challenging to actually get commitment from them to, to very large scale, you know, the scale of funding that was needed.

520
01:05:37,230 --> 01:05:46,470
So we went, we didn't have any funding of the scale needed to do large scale manufacturing and the whole way through March.

521
01:05:47,190 --> 01:05:51,480
You know, it felt like the world wasn't a week gone by by that point.

522
01:05:52,110 --> 01:05:58,050
We assembled a consortium to scale the manufacturing of, I think about nine organisations.

523
01:05:59,100 --> 01:06:05,370
So in February, Vaccine Manufacturing Innovation Centre Halix Cobra.

524
01:06:05,640 --> 01:06:09,120
Oxford Biomedica who took a while to actually commence.

525
01:06:09,120 --> 01:06:12,540
But they were we were talking with them and informally they were, you know,

526
01:06:12,540 --> 01:06:20,930
participating in a phone calls, I think, and then a couple of sort of suppliers.

527
01:06:20,940 --> 01:06:26,999
And then in March the Serum Institute of India and I'd spoken to Ruchi Biologics,

528
01:06:27,000 --> 01:06:31,560
which is the Chinese contract manufacturer, and they said W you excite correct you.

529
01:06:33,840 --> 01:06:38,870
And. I'm sure I'm forgetting other.

530
01:06:38,900 --> 01:06:51,500
Paul. Paul? Yeah. So, but in, in March, you know, we had this with we were having calls, multiple calls over every week,

531
01:06:53,960 --> 01:07:04,280
coordinated by, by me and Adam, one project manager while Karina was doing a lot of work, essentially.

532
01:07:05,390 --> 01:07:08,150
You know, one part of it was how do we do this 200 later on?

533
01:07:08,180 --> 01:07:13,969
Paul You know, the mechanics of how to go in the cells, how do we get the materials to pull fast and enough?

534
01:07:13,970 --> 01:07:16,730
And, you know, we we compressed and compressed the timescale.

535
01:07:16,730 --> 01:07:22,760
So instead of like doing a wrong by August, we decided, you know, the urgency was increasing.

536
01:07:22,760 --> 01:07:27,260
And we, we decided we'd try and get the 200 metre run done in in April.

537
01:07:29,570 --> 01:07:37,010
So that was one strand of work. And then the other was, well, Kobra and Alex had said that they would prepare for what's called inward tech transfer,

538
01:07:37,010 --> 01:07:45,860
taking the manufacturing process and really running it to GMP standards and increasingly turning towards doing that.

539
01:07:45,860 --> 01:07:51,560
And, you know, and saying, well, we actually we really want to do this for real as soon as we possibly can.

540
01:07:55,040 --> 01:08:06,980
And, you know, can we actually really make a batch for the NHS, you know, within, within summer 2020 maybe and.

541
01:08:12,880 --> 01:08:22,810
We had no money. And so, you know, every week I was on this phone call with CEOs of these different contract manufacturers saying,

542
01:08:23,560 --> 01:08:26,770
oh, we're talking to such and such a fund. We'll have some money next week.

543
01:08:27,050 --> 01:08:31,970
It was like magnanimous, you know? John tomorrow.

544
01:08:31,980 --> 01:08:41,130
But it was never John today. And you know, please, guys, please stick with us.

545
01:08:41,150 --> 01:08:45,740
Please don't give away your manufacturing capacity to someone else who's got the money now.

546
01:08:46,190 --> 01:08:51,170
You know, they were they were saying, well, we're going to have to give them you know, we can't commit to do this for you haven't got any money.

547
01:08:52,040 --> 01:08:57,050
And it's you know, ultimately they've all done very well financially out of it.

548
01:08:58,640 --> 01:09:04,880
It was a good business. You know, there was this unique confluence of the right thing to do altruistically.

549
01:09:06,170 --> 01:09:12,650
And also actually there was a very good business case for coming on board with our vaccine programme in the early days.

550
01:09:12,980 --> 01:09:19,220
All the companies that did have done very well, but we needed real money.

551
01:09:22,040 --> 01:09:27,290
And that only changed in April.

552
01:09:28,520 --> 01:09:36,670
And. A couple of other things that happened during during March which.

553
01:09:39,080 --> 01:09:42,850
I'm maybe worth just touching on in terms of my personal experience.

554
01:09:42,850 --> 01:09:46,200
So. I.

555
01:09:47,010 --> 01:09:53,680
I was. You know, I've become increasingly convinced that it was possible to make a vaccine and that

556
01:09:55,060 --> 01:09:59,830
manufacturing and supply was going to be the limiting factor in actually getting it to people.

557
01:10:01,670 --> 01:10:06,220
And it's increasingly public that there wasn't enough funding harmonising and

558
01:10:06,230 --> 01:10:10,520
the government governments were not engaged with the scale of the problem.

559
01:10:11,650 --> 01:10:16,960
And my. My partner is an economist in the School of Government.

560
01:10:17,800 --> 01:10:26,140
Her boss is the former chief economist for different Department for International Development.

561
01:10:27,460 --> 01:10:35,790
And I sent him an email explaining the situation at the end of February and saying that

562
01:10:36,730 --> 01:10:40,090
I saw a lot of middle income countries were going to be in the back of the queue to get.

563
01:10:42,050 --> 01:10:52,450
A real deal. And he put me in touch with a guy called David Kindler is the UK's number two in the world punk too,

564
01:10:53,720 --> 01:11:00,860
between myself and Kate, my partner with a bit of input, a review from Stefan, her boss and Adrian Hill.

565
01:11:01,760 --> 01:11:06,200
We put together a discussion, you know, essentially a briefing note that said.

566
01:11:07,870 --> 01:11:12,939
If the world invested some of basically it was arguing that it was an incredibly

567
01:11:12,940 --> 01:11:17,349
good investment for governments to put in hundreds of millions of pounds,

568
01:11:17,350 --> 01:11:19,510
like then in March 2020.

569
01:11:22,290 --> 01:11:30,030
I'm told I'm told that and then that there was a need for, you know, market commitments to buy the vaccine before the clinical trial results.

570
01:11:33,720 --> 01:11:40,690
I'm told the briefing note had some influence on. COVAX subsequently being set up.

571
01:11:40,750 --> 01:11:49,580
And. And. This is the international organisation principally to supply you to other middle income countries.

572
01:11:49,700 --> 01:11:53,590
That's right. Yeah. Um, but yeah, that was, you know,

573
01:11:53,600 --> 01:12:00,020
all part of this surreal experience is that all of this kind of the World Bank about spending hundreds of millions or billions of pounds.

574
01:12:01,260 --> 01:12:05,190
And we still have short of tens of thousands of pounds.

575
01:12:08,610 --> 01:12:17,790
But there was this sort of track of, you know, I was having those conversations on people on a believe was talking to Chris Whitty and Patrick

576
01:12:17,790 --> 01:12:26,820
Vallance by the end of March 22 I'd sent a message to I think we had a call with Jonathan Van-tam.

577
01:12:27,250 --> 01:12:34,079
I know one or two emails involving Patrick Vallance and Jonathan Van-tam in March 2020, you know,

578
01:12:34,080 --> 01:12:37,650
basis and look, we can do this but you know the manufacturing problem but we can do it.

579
01:12:37,840 --> 01:12:47,909
We can do it in the UK in parallel with the UK Bio Industry Association and set up a vaccine manufacturing what they

580
01:12:47,910 --> 01:12:53,520
call the Vaccine Manufacturing Task Force and subsequently became an arm of the Government's Vaccine Task Force.

581
01:12:53,520 --> 01:12:58,830
But the manufacturing line was set up first and it was it was led by a guy called Ian McKellen,

582
01:12:59,940 --> 01:13:04,500
and he was a former vice president of manufacturing for GSK.

583
01:13:05,370 --> 01:13:11,100
And I think he contacted me on March the 30th email in a phone call.

584
01:13:11,880 --> 01:13:25,600
And basically they had a. In the first couple of calls we had with them, you know, a massive zoom call and dozens of, you know,

585
01:13:25,600 --> 01:13:32,950
well-intentioned and generous people from all the UK bio industry association member companies,

586
01:13:32,950 --> 01:13:36,549
you know, willing to help one out of groups at all to help without Novartis manufacturing.

587
01:13:36,550 --> 01:13:43,420
We had a group set up to help with money, which was basically to help Imperial.

588
01:13:43,420 --> 01:13:52,660
They had a group set up to do will fill and finish putting the vaccines into vials and a group set up to do a deal with supply chain.

589
01:13:54,120 --> 01:13:58,680
Very, very sensible. Very important. And.

590
01:14:02,090 --> 01:14:09,930
To start with. I think they thought that they were you. If the assumption was that we wouldn't have a a large scale manufacturing plant.

591
01:14:12,650 --> 01:14:16,310
And they said that they were going to take over.

592
01:14:16,520 --> 01:14:23,960
So the first couple of meetings were a bit weird. It was like, you know, what do I actually owe for the plant, you know?

593
01:14:25,610 --> 01:14:35,459
And the. But it turned into a very, very productive and very supportive relationship.

594
01:14:35,460 --> 01:14:38,730
And within a week of, I think, April 7th.

595
01:14:40,050 --> 01:14:43,740
He had asked me to put put together a plan.

596
01:14:43,740 --> 01:14:47,700
Well, what would it take to buy the capacity? You know, I said,

597
01:14:47,700 --> 01:14:54,630
I think we need to buy a capacity in the three of three contract manufacturers we had that were potentially for supplying the kind of three,

598
01:14:54,870 --> 01:15:03,350
three sites that might supply the U.K., like COBRA to buy American to internationally etc. maybe talk about into non-European.

599
01:15:03,360 --> 01:15:14,940
But later up the. The task force was interested in UK supply primarily.

600
01:15:15,930 --> 01:15:23,400
And you know, I had been thinking well by this point, well we just need to book the mine, you know, hire the facilities for the rest of the year.

601
01:15:24,460 --> 01:15:28,950
And. I said this to me and I said, Well, you know, what's it what would it cost?

602
01:15:29,190 --> 01:15:33,840
You know, write a plan. And I wrote a few slides.

603
01:15:34,750 --> 01:15:36,270
It's like it needs to be simpler.

604
01:15:36,840 --> 01:15:44,040
And I ended up basically boiling it down to a single slide where said, you know, we could do this for £65 million for the year.

605
01:15:45,690 --> 01:15:51,960
And I was at pains to say, but we don't you know, you don't need to put all that money at risk to begin with.

606
01:15:52,230 --> 01:15:56,760
You know, you could bail out if the trial results in May or this point, you know.

607
01:15:57,240 --> 01:16:00,330
So actually, all we're really asking for is £12 billion upfront.

608
01:16:00,690 --> 01:16:04,950
It wasn't even though it was a huge amount of money for me, I'd never asked for that much money for anything before.

609
01:16:06,860 --> 01:16:14,250
But it's like, no, you just need to ask for £65 million and a week after that.

610
01:16:17,760 --> 01:16:20,999
We want to, you know, ride in.

611
01:16:21,000 --> 01:16:24,810
And his task force will help you with a plan and play set up a cause.

612
01:16:25,240 --> 01:16:37,980
Harsh on business Secretary Huntoon, sir, we're talking about the clinical trial and the phone and all these presentations on your functional side.

613
01:16:38,490 --> 01:16:43,910
And very soon after that, we had a, you know, commitments of of.

614
01:16:44,750 --> 01:16:49,760
£65 million. But by that time, the government vaccine taskforce had been established.

615
01:16:50,170 --> 01:16:53,630
It was formally only established, I think, on the 1st of May. Oh, right.

616
01:16:54,200 --> 01:16:57,470
Or at least that's when Kate Bingham came on board.

617
01:16:59,900 --> 01:17:05,720
But certainly through April, there was you know,

618
01:17:06,140 --> 01:17:12,590
we were in contact with government through through this being a vaccine manufacturing taskforce and was connected into government.

619
01:17:14,060 --> 01:17:21,080
And, you know, the there were clearly people in the civil service who had been briefed.

620
01:17:21,230 --> 01:17:27,550
You know, it's your job now to make this happen. You know, there was someone to pick up the phone to and go on from.

621
01:17:27,740 --> 01:17:34,220
Do you feel when you heard you've got 65 million? I know.

622
01:17:35,540 --> 01:17:41,089
Please. Obviously, I mean it. But to be honest, there was still there was so much other stuff going on.

623
01:17:41,090 --> 01:17:49,070
I was like, okay, well, what's got those one problem solved? But, you know, you know, I thought the whole thing felt so real.

624
01:17:52,070 --> 01:17:58,010
It was like a one line email pretty much, and then we didn't actually have a contract.

625
01:17:58,160 --> 01:18:02,600
So still it's gone back to going back to all our partners and saying, Well, look,

626
01:18:02,600 --> 01:18:06,950
we've got this promise of the money, but we still can't give you a contract or the actual money.

627
01:18:06,950 --> 01:18:10,010
But believe us, so everything run on trust.

628
01:18:14,770 --> 01:18:19,380
And by that point, civil servants, you know, would have already been some scandal about PPE contracts.

629
01:18:19,400 --> 01:18:23,590
The government was worried about due process in the contracts and so on.

630
01:18:25,180 --> 01:18:30,190
Things took a little bit of time to finally sort out, but by that point,

631
01:18:30,190 --> 01:18:41,950
the negotiation with AstraZeneca was on and prior to that Mark was just like a lot going on and it was a whole nother parallel track of,

632
01:18:42,370 --> 01:18:52,420
you know, something that £65 million was to fund manufacturing at 200 litre scale for the UK primarily and.

633
01:18:53,640 --> 01:18:59,170
I done some months, so I've got a spreadsheet for the 3rd of March, I think.

634
01:18:59,170 --> 01:19:03,270
Got something on Lauren's calls. I didn't show it to anyone at the time.

635
01:19:03,270 --> 01:19:07,250
It was too, you know, felt too preposterous. A lot of people think, oh,

636
01:19:07,280 --> 01:19:13,530
was that's called that is a spreadsheet called billion those scale essentially doing the as well how would

637
01:19:13,530 --> 01:19:19,790
we do this if we wanted to make a billion doses and it was apparent we couldn't do that on 200 metres scale.

638
01:19:19,790 --> 01:19:23,670
I couldn't do it in the UK. And so how many doses? There's 200 litres.

639
01:19:23,960 --> 01:19:27,030
When you say do you want a little scale, that's just the size of the best. Yeah, that's right.

640
01:19:27,120 --> 01:19:29,849
Yes, right. Yeah. That's an important that's an important question.

641
01:19:29,850 --> 01:19:36,509
So 200 litres originally our original calculations were that would make a million doses and that turned out we didn't,

642
01:19:36,510 --> 01:19:42,390
we weren't able to get quite that much, but a few hundred thousand doses.

643
01:19:47,420 --> 01:19:56,780
Yeah, that's right. So, yeah, there was this one was one truck of work that was technically doing as a too early to scale a pole.

644
01:19:57,140 --> 01:20:06,320
It was another track of work, which was, well, how do we, you know, essentially the business side of it and and the business side of UK supply,

645
01:20:06,320 --> 01:20:12,950
you know, how do we make it, you know, come to a deal that will allow it to be actually made for real for UK supply.

646
01:20:13,380 --> 01:20:19,330
And there was another truck which was well actually covered bigger and can we do something that was globally relevant because like,

647
01:20:19,460 --> 01:20:27,360
you know, I remember so how many of us, 65 is all there in India and there's quite a lot, you know, and.

648
01:20:28,330 --> 01:20:33,270
You know, it looked like. What might be needed would be billions of doses.

649
01:20:34,800 --> 01:20:37,040
But that was just not the, you know, the idea, you know,

650
01:20:37,050 --> 01:20:41,520
and thinking of making a billion doses before any patient had been injected with a product in a trial.

651
01:20:42,450 --> 01:20:51,850
So I'd have been laughed out of town, but. And there was another, you know, another strand of work on how to do that.

652
01:20:52,120 --> 01:20:58,360
And essentially, as soon as the 65 million for the UK was agreed, as soon as the 200 leads a scale plan was agreed,

653
01:20:58,780 --> 01:21:06,070
we'd already have begun staff who had begun talking about well, well we privately called stream two for the UK.

654
01:21:07,190 --> 01:21:16,630
I say we I mean me and Ian McCubbin on the contract manufacturers which was thousand leads a scale within the economy

655
01:21:17,830 --> 01:21:22,630
various people were on the record a lot of points in the UK couldn't manufacture vaccines in the relevant scale.

656
01:21:23,320 --> 01:21:27,580
There was no weather at 1008 to scale for this sort of product in the UK.

657
01:21:28,090 --> 01:21:35,080
But we figured either physically you could fit the thousand Lisa scale thing, you know, equipment in talks for biomedical clean rooms.

658
01:21:37,820 --> 01:21:42,440
And we figured out the equipment actually didn't cost costs of some million.

659
01:21:42,440 --> 01:21:45,660
But, you know, in the scheme of things, it was not done.

660
01:21:45,950 --> 01:21:51,590
At the same time that we were asking for the 200 litres, you know,

661
01:21:52,370 --> 01:21:57,949
we already knew that really what we wanted was 2000 litres, but we didn't think we could make the ask quite.

662
01:21:57,950 --> 01:22:03,050
Yeah. So how did I feel when we got the 65 million?

663
01:22:03,080 --> 01:22:11,389
Great. But it was just so much a little stuff to do. I think perhaps we better stop because you've got something else to stop.

664
01:22:11,390 --> 01:22:11,690
Because you've.